Developing a new ventricular assist device (VAD) Vegard Tuseth MD of NuHeart AS.
Photo by Mikita Karasiou on Unsplash
What is it about?
Vegard Tuseth founded Nuheart AS in 2014 to develop a ventricular assist device (VAD), for patients with severe heart failure. He talks about his move from a senior clinical position in a large teaching hospital to setting up the company based in Bergen, Norway single-handedly.
Why is it important?
The implantable VAD is designed to treat patients with severe heart failure without the need for surgery. The catheter-based delivery and placement system draws on the latest methods and technologies to provide high levels of efficiency and stability.
The following have contributed to this page: Judith Ozkan